Short Interest in GlycoMimetics, Inc. (NASDAQ:GLYC) Decreases By 13.5%

GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 1,350,000 shares, a decline of 13.5% from the April 15th total of 1,560,000 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is presently […]

Related Keywords

Danielm Junius , ,Glycomimetics Company Profile ,Securities Exchange Commission ,Nasdaq ,Letko Brosseau Associates Inc ,Glycomimetics Inc ,Get Rating ,Exchange Commission ,Director Daniel ,Street Corp ,Sigma Advisers ,Sigma Investments ,Letko Brosseau ,Mimetics Stock Down ,Glycomimetics Daily ,Glycomimetics ,Nasdaq Glyc ,Glyc ,Medical ,Stocks ,Options ,Put ,Call ,